GEODE CAPITAL MANAGEMENT, LLC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 149 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$59,155,597
-56.7%
1,554,826
+3.8%
0.01%
-56.2%
Q2 2023$136,503,297
+12.6%
1,498,389
-18.5%
0.02%0.0%
Q1 2023$121,252,929
+133893.0%
1,838,279
+5.0%
0.02%
+23.1%
Q4 2022$90,492
-99.9%
1,750,001
+3.5%
0.01%
-27.8%
Q3 2022$115,509,000
+58.6%
1,691,202
+5.0%
0.02%
+63.6%
Q2 2022$72,811,000
-4.1%
1,610,162
+7.8%
0.01%
+22.2%
Q1 2022$75,885,000
+18.6%
1,493,520
+10.4%
0.01%
+12.5%
Q4 2021$63,961,000
+63.3%
1,352,829
+13.8%
0.01%
+60.0%
Q3 2021$39,169,000
-44.6%
1,188,392
+6.3%
0.01%
-50.0%
Q2 2021$70,666,000
+57.3%
1,118,135
+6.8%
0.01%
+42.9%
Q1 2021$44,923,000
-16.1%
1,046,913
+11.8%
0.01%
-22.2%
Q4 2020$53,569,000
+102.3%
936,533
+6.7%
0.01%
+80.0%
Q3 2020$26,483,000
-6.4%
877,814
+1.4%
0.01%
-16.7%
Q2 2020$28,279,000
+27.5%
865,898
+4.6%
0.01%0.0%
Q1 2020$22,183,000
-44.9%
828,049
-37.1%
0.01%
+50.0%
Q4 2019$40,292,000
+166.9%
1,315,874
+110.0%
0.00%0.0%
Q3 2019$15,098,000
+3.1%
626,750
+8.4%
0.00%0.0%
Q2 2019$14,646,000
+54.1%
577,997
+18.6%
0.00%
+100.0%
Q1 2019$9,504,000
-14.6%
487,432
-42.2%
0.00%0.0%
Q4 2018$11,128,000
+67.7%
843,698
+126.0%
0.00%0.0%
Q3 2018$6,636,000
-16.3%
373,246
+3.6%
0.00%0.0%
Q2 2018$7,924,000
+139.0%
360,202
+140.1%
0.00%
+100.0%
Q1 2018$3,316,000
+4.5%
149,992
+2.6%
0.00%0.0%
Q4 2017$3,172,000146,1950.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders